HEADER GENE REGULATION/INHIBITOR 08-JAN-21 7LBT TITLE CRYSTAL STRUCTURE OF THE SECOND BROMODOMAIN (BD2) OF HUMAN BRD3 BOUND TITLE 2 TO ERK5-IN-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD3, KIAA0043, RING3L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BET, ERK5, DUAL BRD-KINASE INHIBITOR, GENE REGULATION, GENE KEYWDS 2 REGULATION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.R.KARIM,M.J.BIKOWITZ,E.SCHONBRUNN REVDAT 4 18-OCT-23 7LBT 1 REMARK REVDAT 3 24-NOV-21 7LBT 1 JRNL REVDAT 2 17-NOV-21 7LBT 1 JRNL REVDAT 1 14-JUL-21 7LBT 0 JRNL AUTH R.M.KARIM,M.J.BIKOWITZ,A.CHAN,J.Y.ZHU,D.GRASSIE,A.BECKER, JRNL AUTH 2 N.BERNDT,S.GUNAWAN,N.J.LAWRENCE,E.SCHONBRUNN JRNL TITL DIFFERENTIAL BET BROMODOMAIN INHIBITION BY JRNL TITL 2 DIHYDROPTERIDINONE AND PYRIMIDODIAZEPINONE KINASE JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 64 15772 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34710325 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01096 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2_3472 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 24876 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.4000 - 5.1373 1.00 3572 150 0.1677 0.1888 REMARK 3 2 5.1373 - 4.0902 1.00 3456 144 0.1508 0.1834 REMARK 3 3 4.0902 - 3.5768 0.99 3400 141 0.1692 0.2003 REMARK 3 4 3.5768 - 3.2515 0.99 3399 142 0.1896 0.2252 REMARK 3 5 3.2515 - 3.0194 0.99 3360 140 0.2513 0.3238 REMARK 3 6 3.0194 - 2.8419 0.99 3343 139 0.2540 0.2952 REMARK 3 7 2.8419 - 2.7000 0.98 3350 140 0.2696 0.3345 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -12.3268 -26.4237 -0.7802 REMARK 3 T TENSOR REMARK 3 T11: 0.1604 T22: 0.1819 REMARK 3 T33: 0.1736 T12: -0.0082 REMARK 3 T13: -0.0111 T23: -0.0084 REMARK 3 L TENSOR REMARK 3 L11: 0.1409 L22: 0.2780 REMARK 3 L33: 0.3884 L12: -0.0251 REMARK 3 L13: -0.0461 L23: -0.2251 REMARK 3 S TENSOR REMARK 3 S11: -0.0059 S12: -0.0162 S13: 0.0061 REMARK 3 S21: 0.0432 S22: 0.0125 S23: -0.0119 REMARK 3 S31: -0.0601 S32: -0.0542 S33: -0.0075 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 SELECTION : (CHAIN B AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 ATOM PAIRS NUMBER : 1272 REMARK 3 RMSD : NULL REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 SELECTION : (CHAIN C AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 ATOM PAIRS NUMBER : 1272 REMARK 3 RMSD : NULL REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 SELECTION : (CHAIN D AND (RESID 308 THROUGH 367 OR REMARK 3 RESID 369 THROUGH 410 OR RESID 412 REMARK 3 THROUGH 416)) REMARK 3 ATOM PAIRS NUMBER : 1272 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LBT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-21. REMARK 100 THE DEPOSITION ID IS D_1000253737. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24881 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 19.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 7.421 REMARK 200 R MERGE (I) : 0.16900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.5200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.51 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.740 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7L9L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.12 M ALCOHOLS (0.2M 1,6-HEXANEDIOL; REMARK 280 0.2M 1-BUTANOL, 0.2M 1,2-PROPANEDIOL; 0.2M 2-PROPANOL; 0.2M 1,4- REMARK 280 BUTANEDIOL; 0.2M 1,3-PROPANEDIOL), 0.1MBUFFER SYSTEM 3 (PH 8.5 REMARK 280 TRIS (BASE) AND BICINE 1.0M EACH), 37.5% V/VPRECIPITANT MIX 4 REMARK 280 (25% V/V MPD; 25% PEG 1000; 25% W/V PEG 3350), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.34500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.34500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.14500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 82.59500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.14500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 82.59500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 54.34500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.14500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 82.59500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 54.34500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.14500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 82.59500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 306 REMARK 465 LYS B 307 REMARK 465 GLY C 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG B 363 O HOH B 601 2.10 REMARK 500 OG SER B 309 O HOH B 602 2.18 REMARK 500 ND1 HIS D 395 O HOH D 601 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU C 308 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 LYS C 325 CA - CB - CG ANGL. DEV. = 17.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU C 308 SER C 309 142.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VYJ D 501 DBREF 7LBT A 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7LBT B 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7LBT C 306 416 UNP Q15059 BRD3_HUMAN 306 416 DBREF 7LBT D 306 416 UNP Q15059 BRD3_HUMAN 306 416 SEQRES 1 A 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 A 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 A 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 A 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 A 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 A 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 A 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 A 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 A 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 B 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 B 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 B 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 B 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 B 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 B 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 B 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 B 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 B 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 C 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 C 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 C 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 C 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 C 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 C 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 C 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 C 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 C 111 MET ARG PHE ALA LYS MET PRO SEQRES 1 D 111 GLY LYS LEU SER GLU HIS LEU ARG TYR CYS ASP SER ILE SEQRES 2 D 111 LEU ARG GLU MET LEU SER LYS LYS HIS ALA ALA TYR ALA SEQRES 3 D 111 TRP PRO PHE TYR LYS PRO VAL ASP ALA GLU ALA LEU GLU SEQRES 4 D 111 LEU HIS ASP TYR HIS ASP ILE ILE LYS HIS PRO MET ASP SEQRES 5 D 111 LEU SER THR VAL LYS ARG LYS MET ASP GLY ARG GLU TYR SEQRES 6 D 111 PRO ASP ALA GLN GLY PHE ALA ALA ASP VAL ARG LEU MET SEQRES 7 D 111 PHE SER ASN CYS TYR LYS TYR ASN PRO PRO ASP HIS GLU SEQRES 8 D 111 VAL VAL ALA MET ALA ARG LYS LEU GLN ASP VAL PHE GLU SEQRES 9 D 111 MET ARG PHE ALA LYS MET PRO HET VYJ A 501 47 HET VYJ B 501 47 HET VYJ C 501 47 HET VYJ D 501 47 HETNAM VYJ 11-CYCLOPENTYL-2-({2-ETHOXY-4-[4-(4-METHYLPIPERAZIN-1- HETNAM 2 VYJ YL)PIPERIDINE-1-CARBONYL]PHENYL}AMINO)-5-METHYL-5,11- HETNAM 3 VYJ DIHYDRO-6H-PYRIMIDO[4,5-B][1,4]BENZODIAZEPIN-6-ONE FORMUL 5 VYJ 4(C36 H46 N8 O3) FORMUL 9 HOH *78(H2 O) HELIX 1 AA1 GLY A 306 SER A 324 1 19 HELIX 2 AA2 HIS A 327 TRP A 332 1 6 HELIX 3 AA3 PRO A 333 TYR A 335 5 3 HELIX 4 AA4 ASP A 339 GLU A 344 1 6 HELIX 5 AA5 ASP A 347 ILE A 352 1 6 HELIX 6 AA6 ASP A 357 GLY A 367 1 11 HELIX 7 AA7 ASP A 372 ASN A 391 1 20 HELIX 8 AA8 HIS A 395 LYS A 414 1 20 HELIX 9 AA9 SER B 309 SER B 324 1 16 HELIX 10 AB1 HIS B 327 TRP B 332 1 6 HELIX 11 AB2 PRO B 333 TYR B 335 5 3 HELIX 12 AB3 ASP B 347 ILE B 352 1 6 HELIX 13 AB4 ASP B 357 GLY B 367 1 11 HELIX 14 AB5 ASP B 372 ASN B 391 1 20 HELIX 15 AB6 HIS B 395 LYS B 414 1 20 HELIX 16 AB7 LEU C 308 LEU C 323 1 16 HELIX 17 AB8 SER C 324 LYS C 326 5 3 HELIX 18 AB9 HIS C 327 TRP C 332 1 6 HELIX 19 AC1 PRO C 333 TYR C 335 5 3 HELIX 20 AC2 ASP C 347 ILE C 352 1 6 HELIX 21 AC3 ASP C 357 GLY C 367 1 11 HELIX 22 AC4 ASP C 372 ASN C 391 1 20 HELIX 23 AC5 HIS C 395 LYS C 414 1 20 HELIX 24 AC6 LYS D 307 LEU D 323 1 17 HELIX 25 AC7 SER D 324 LYS D 326 5 3 HELIX 26 AC8 HIS D 327 TRP D 332 1 6 HELIX 27 AC9 PRO D 333 TYR D 335 5 3 HELIX 28 AD1 ASP D 339 GLU D 344 1 6 HELIX 29 AD2 ASP D 347 ILE D 352 1 6 HELIX 30 AD3 ASP D 357 GLY D 367 1 11 HELIX 31 AD4 ASP D 372 ASN D 391 1 20 HELIX 32 AD5 HIS D 395 LYS D 414 1 20 SITE 1 AC1 7 TRP A 332 PRO A 333 PHE A 334 LEU A 345 SITE 2 AC1 7 ASN A 391 VAL A 397 HOH A 612 SITE 1 AC2 6 PRO B 333 PHE B 334 LEU B 345 TYR B 390 SITE 2 AC2 6 ASN B 391 HOH B 617 SITE 1 AC3 9 TRP C 332 PRO C 333 PHE C 334 LEU C 343 SITE 2 AC3 9 LEU C 345 TYR C 390 ASN C 391 VAL C 397 SITE 3 AC3 9 HOH C 608 SITE 1 AC4 6 PRO D 333 PHE D 334 GLU D 344 LEU D 345 SITE 2 AC4 6 ASN D 391 VAL D 397 CRYST1 100.290 165.190 108.690 90.00 90.00 90.00 C 2 2 21 32 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009971 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006054 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009200 0.00000